Skip to main content
. 2021 Aug 30;2021:3471764. doi: 10.1155/2021/3471764

Table 4.

Univariate analysis of influence on death in ECMO patients.

Variables n The hospitalized death group (n = 56) The hospitalized survival group (n = 68) P
Age (year) 124 61.91 ± 16.80 55.14 ± 9.45 0.006
Proportion of female (%) 37 18 (32.14) 19 (27.94) 0.611
BMI (kg/m2) 124 23.61 ± 2.15 23.42 ± 2.93 0.621
Hypertension (%) 49 22 (39.29) 27 (39.71) 0.962
Diabetes (%) 25 5 (8.93) 20 (29.41) 0.005
Hyperlipidemia (%) 5 1 (1.79) 4 (5.88) 0.248
Long history of oral anticoagulants (%) 10 3 (5.35) 7 (10.29) 0.315
History of myocardial infarction (%) 9 6 (10.71) 3 (4.41) 0.178
Smoking history (%) 32 11 (19.64) 21 (30.88) 0.155
History of COPD (%) 1 0 (0.00) 1 (1.47) 0.362
History of chronic kidney disease (%) 2 0 (0.00) 2 (2.94) 0.196
Cardiac arrest (%) 81 44 (78.57) 37 (54.41) 0.005
Drainage tube model (F) 124 21.00 (18.00, 24.00) 20.00 (15.00, 24.00) 0.322
Perfusion tube model (F) 124 16.00 (14.00, 17.00) 16.00 (15.00, 23.00) 0.075
Drainage-perfusion tube ipsilateral (%) 64 32 (57.14) 32 (47.06) 0.263
Distal perfusion tube DPC (%) 43 18 (32.14) 25 (36.76) 0.591
ECMO first auxiliary time (h) 124 37.50 (0.33, 296.20) 106.80 (10.30, 405.90) 0.001
Bleeding complications (%) 13 5 (8.93) 8 (11.76) 0.608
Acute stroke (%) 6 2 (3.57) 4 (5.88) 0.551
Hyperbilirubinemia (%) 63 36 (64.29) 27 (39.71) 0.006
ALI (%) 16 6 (10.71) 10 (14.71) 0.509